Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$266K Sell
765
-881
-54% -$314K ﹤0.01% 965
2025
Q4
$539K Sell
1,646
-38,739
-96% -$12.3M 0.01% 444
2025
Q3
$11.4M Buy
40,385
+32,077
+386% +$9.3M 0.21% 64
2025
Q2
$2.32M Sell
8,308
-8,245
-50% -$2.34M 0.05% 192
2025
Q1
$5.16M Buy
+16,553
New +$4.89M 0.14% 90
2024
Q4
Sell
-758
Closed -$244K 582
2024
Q3
$244K Buy
+758
New +$248K 0.01% 478
2024
Q2
Sell
-4,118
Closed -$1.17M 522
2024
Q1
$1.17M Buy
+4,118
New +$1.2M 0.03% 159
2023
Q4
Sell
-2,271
Closed -$610K 315
2023
Q3
$610K Sell
2,271
-25
-1% -$6.24K 0.01% 195
2023
Q2
$510K Buy
+2,296
New +$533K 0.01% 208
2022
Q2
Sell
-1,994
Closed -$482K 248
2022
Q1
$482K Buy
+1,994
New +$458K 0.01% 168
2021
Q3
Sell
-2,190
Closed -$534K 256
2021
Q2
$534K Buy
+2,190
New +$539K 0.02% 177
2018
Q1
Sell
-10,176
Closed -$1.77M 184
2017
Q4
$1.77M Buy
+10,176
New +$1.8M 0.19% 76

Other funds holding AMGN

DRW Securities's AMGN Position: Q1 2026 in Review

DRW Securities reduced its Amgen (AMGN) stake by 54% in Q1 2026, selling an estimated $314K and leaving 765 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

DRW Securities first reported a position in AMGN in Q4 2017 and has held it in 12 quarters since. The position peaked at $11.4M in Q3 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • DRW Securities held 765 shares of Amgen worth $266K as of Q1 2026.
  • DRW Securities sold 881 Amgen shares in Q1 2026, an estimated $314K.
  • Amgen made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #965 holding.
  • DRW Securities first reported a position in Amgen in Q4 2017 and has held it in 12 quarters since.
  • DRW Securities's Amgen position peaked at $11.4M in Q3 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.